Status:
UNKNOWN
Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA)
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Aneurysmal Subarachnoid Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This was a randomized, single-center trial. On the basis of standard-of-care, patients in the treatment group inhaled H2-O2 (66% hydrogen; 33% oxygen) at 3 L/min via nasal cannula by using the Hydroge...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Signed informed consent
- Must be admitted within 72 hours after aneurysm rupture
Exclusion
- physical disability caused by any reason before the onset of the disease
- dementia or mental illness before the onset of the disease
- more than 72 hours after aneurysm rupture admitted to hospital for treatment
- do not cooperate with the treatment
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2024
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT05282836
Start Date
March 15 2022
End Date
March 15 2024
Last Update
March 16 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.